Anti-T Lymphocyte Globulin Plus Posttransplant Cyclophosphamide 25 Mg/Kg Versus Posttransplant Cyclophosphamide 50 Mg/Kg in Patients with Acute Leukemias

Researchers compared the engraftment days, graft-versus-host disease development, relapse, and overall survival rates in patients using myeloablative/reduced intensity conditioning regimens with posttransplant cyclophosphamide (PTCy) with anti-T lymphocyte globulin and PTCy.